Citation Impact

Citing Papers

Neutralizing antibody response during acute and chronic hepatitis C virus infection
2004 StandoutNobel
Dendrimer-RNA nanoparticles generate protective immunity against lethal Ebola, H1N1 influenza, and Toxoplasma gondii challenges with a single dose
2016
Engineered receptors for soluble cellular communication and disease sensing
2024 StandoutNatureNobel
Platelet factor 4–induced T H 1-T reg polarization suppresses antitumor immunity
2024 StandoutScienceNobel
Administration of nucleoside-modified mRNA encoding broadly neutralizing antibody protects humanized mice from HIV-1 challenge
2017 StandoutNobel
Therapeutic strategies for Alzheimer's disease
2002
A Toll-like receptor recognizes bacterial DNA
2000 StandoutNature
Presenilins are essential for regulating neurotransmitter release
2009 StandoutNatureNobel
Immune Activation in Brain Aging and Neurodegeneration: Too Much or Too Little?
2009
Conditional Inactivation of Presenilin 1 Prevents Amyloid Accumulation and Temporarily Rescues Contextual and Spatial Working Memory Impairments in Amyloid Precursor Protein Transgenic Mice
2005
Transforming growth factor–β3 is required for secondary palate fusion
1995 Standout
CD22 blockade restores homeostatic microglial phagocytosis in ageing brains
2019 StandoutNatureNobel
A Comprehensive Behavioral Test Battery to Assess Learning and Memory in 129S6/Tg2576 Mice
2016
Activation of Wnt signaling rescues neurodegeneration and behavioral impairments induced by β-amyloid fibrils
2003
Amyloid Oligomers Exacerbate Tau Pathology in a Mouse Model of Tauopathy
2012 Standout
Enlarged Scale Chemical Synthesis and Range of Activity of Drosocin, an O‐Glycosylated Antibacterial Peptide of Drosophila
1996
Immunization reverses memory deficits without reducing brain Aβ burden in Alzheimer's disease model
2002
Vaccination of Chimpanzees With Plasmid DNA Encoding the Hepatitis C Virus (HCV) Envelope E2 Protein Modified the Infection After Challenge With Homologous Monoclonal HCV
2000
Amyloid-β protein dimers isolated directly from Alzheimer's brains impair synaptic plasticity and memory
2008 Standout
Amyloid β-degrading cryptidases: insulin degrading enzyme, presequence peptidase, and neprilysin
2008
NLRP3 is activated in Alzheimer’s disease and contributes to pathology in APP/PS1 mice
2012 StandoutNature
Immune attack: the role of inflammation in Alzheimer disease
2015 Standout
Prospects for a vaccine against the hepatitis C virus
2005 StandoutNatureNobel
Protein folding and misfolding
2003 StandoutNature
Correlation between cognitive deficits and Aβ deposits in transgenic APP+PS1 mice
2001
Safety and Immunogenicity of Tyrosinase DNA Vaccines in Patients with Melanoma
2007
Self-replicating Semliki Forest virus RNA as recombinant vaccine
1994
A β-arrestin 2 Signaling Complex Mediates Lithium Action on Behavior
2008 StandoutNobel
Peptide‐Based Inhibitors of Amyloid Assembly
2006
Monovalent single‐chain Fv fragments and bivalent miniantibodies bound to vesicular stomatitis virus protect against lethal infection
1996 StandoutNobel
Genetic adjuvants for DNA vaccines
2001
Restoring function in exhausted CD8 T cells during chronic viral infection
2005 StandoutNatureNobel
APP Processing and Synaptic Function
2003
HIV as the cause of AIDS
1996 StandoutNobel
Roles of amyloid precursor protein and its fragments in regulating neural activity, plasticity and memory
2003
A Dominant Complement Fixation Pathway for Pneumococcal Polysaccharides Initiated by SIGN-R1 Interacting with C1q
2006 StandoutNobel
Structure-based design of non-natural amino-acid inhibitors of amyloid fibril formation
2011 StandoutNatureNobel
Neuropathology of human Alzheimer disease after immunization with amyloid-β peptide: a case report
2003 Standout
HIV-1 entry into CD4+ cells is mediated by the chemokine receptor CC-CKR-5
1996 StandoutNature
The role of microglia in amyloid clearance from the AD brain
2010
Genetic heterologous prime–boost vaccination strategies for improved systemic and mucosal immunity
2009
Prime–boost immunization with poxvirus or adenovirus vectors as a strategy to develop a protective vaccine for HIV-1
2010
Pathways towards and away from Alzheimer's disease
2004 StandoutNature
Molecular Mechanisms of Amyloidosis
2003 Standout
Cytokines in clinical cancer immunotherapy
2018
Genetically engineered mouse models of neurodegenerative diseases
2002
Immune Recognition of Foreign DNA
1999
Soluble amyloid precursor protein (APP) regulates transthyretin and Klotho gene expression without rescuing the essential function of APP
2010 StandoutNobel
Proteinase-resistant factors in human erythrocyte membranes mediate CD4-dependent fusion with cells expressing human immunodeficiency virus type 1 envelope glycoproteins
1995
Appearance of heat shock proteins during the induction of multiple flagella in Naegleria gruberi.
1980
Immunization with HIV Gag targeted to dendritic cells followed by recombinant New York vaccinia virus induces robust T-cell immunity in nonhuman primates
2011 StandoutNobel
A Strategy for the Chemoselective Synthesis of O-Linked Glycopeptides with Native Sugar−Peptide Linkages
1997 StandoutNobel
CC CKR5: A RANTES, MIP-1α, MIP-1β Receptor as a Fusion Cofactor for Macrophage-Tropic HIV-1
1996 StandoutScience
Protection against malaria by immunization with plasmid DNA encoding circumsporozoite protein.
1994
HIV Envelope Binding by Macrophage-Expressed gp340 Promotes HIV-1 Infection
2008 StandoutNobel
The heat-shock response in xenopus oocytes is controlled at the translational level
1982 StandoutNobel
Place cell firing correlates with memory deficits and amyloid plaque burden in Tg2576 Alzheimer mouse model
2008 StandoutNobel
DEC-205 receptor on dendritic cells mediates presentation of HIV gag protein to CD8 + T cells in a spectrum of human MHC I haplotypes
2007 StandoutNobel
Potentiation of Simian Immunodeficiency Virus (SIV)-Specific CD4+ and CD8+ T Cell Responses by a DNA-SIV and NYVAC-SIV Prime/Boost Regimen
2001
The Amyloid Hypothesis of Alzheimer's Disease: Progress and Problems on the Road to Therapeutics
2002 StandoutScience
β-Phenylethylamines and the isoquinoline alkaloids
2004
Induction of AIDS Virus-Specific CTL Activity in Fresh, Unstimulated Peripheral Blood Lymphocytes from Rhesus Macaques Vaccinated with a DNA Prime/Modified Vaccinia Virus Ankara Boost Regimen
2000
One-Component Multifunctional Sequence-Defined Ionizable Amphiphilic Janus Dendrimer Delivery Systems for mRNA
2021 StandoutNobel
Integrated NY-ESO-1 antibody and CD8+T-cell responses correlate with clinical benefit in advanced melanoma patients treated with ipilimumab
2011 StandoutNobel
Lack of Neurodegeneration in Transgenic Mice Overexpressing Mutant Amyloid Precursor Protein Is Associated with Increased Levels of Transthyretin and the Activation of Cell Survival Pathways
2002
A Perspective on Cancer Cell Metastasis
2011 StandoutScience
mRNA Vaccine Delivery Using Lipid Nanoparticles
2016
Enhanced T-Cell Immunogenicity and Protective Efficacy of a Human Immunodeficiency Virus Type 1 Vaccine Regimen Consisting of Consecutive Priming with DNA and Boosting with Recombinant Fowlpox Virus
1998
Crosslinked HIV-1 envelope–CD4 receptor complexes elicit broadly cross-reactive neutralizing antibodies in rhesus macaques
2002
Alphavirus-based expression vectors: strategies and applications.
1996 StandoutNobel
Therapeutic Vaccines for Chronic Infections
2004 Science
Reversible Memory Loss in a Mouse Transgenic Model of Alzheimer's Disease
2002
Pathogenesis of human immunodeficiency virus infection
1993
Toxic Proteins in Neurodegenerative Disease
2002 Science
DNA Immunization against Herpes Simplex Virus: Enhanced Efficacy Using a Sindbis Virus-Based Vector
1998
DNA vaccines: protective immunizations by parenteral, mucosal, and gene-gun inoculations.
1993
Alzheimer's Disease Is a Synaptic Failure
2002 StandoutScience
Immune responses to plasmid DNA encoding the hepatitis C virus core protein
1995 StandoutNobel
Aromatic Sulfonyl Fluorides Covalently Kinetically Stabilize Transthyretin to Prevent Amyloidogenesis while Affording a Fluorescent Conjugate
2013 StandoutNobel
Lysis of tumor cells by natural killer cells in mice is impeded by platelets.
1999
Casting Metal Nanowires Within Discrete Self-Assembled Peptide Nanotubes
2003 StandoutScience
Targeted Delivery of mRNA with One-Component Ionizable Amphiphilic Janus Dendrimers
2021 StandoutNobel
Chemical Reaction-Inspired Crystal Growth of a Coordination Polymer toward Morphology Design and Control
2006 StandoutNobel
Broad Neutralization of Human Immunodeficiency Virus Type 1 (HIV-1) Elicited from Human Rhinoviruses That Display the HIV-1 gp41 ELDKWA Epitope
2009
Quantitative Measurements of Recombinant HIV Surface Glycoprotein 120 Binding to Several Glycosphingolipids Expressed in Planar Supported Lipid Bilayers
2002
The Caenorhabditis elegans IMPAS gene, imp-2, is essential for development and is functionally distinct from related presenilins
2004 StandoutNobel
Dendritic cell targeted HIV gag protein vaccine provides help to a DNA vaccine including mobilization of protective CD8 + T cells
2010 StandoutNobel
HIV VACCINES
2005
Nitrated Confined Imidodiphosphates Enable a Catalytic Asymmetric Oxa-Pictet–Spengler Reaction
2016 StandoutNobel
The role of cytokine DNAs as vaccine adjuvants for optimizing cellular immune responses
2004
The Relationship between Aβ and Memory in the Tg2576 Mouse Model of Alzheimer's Disease
2002
The immunobiology of TSE diseases
2001
Microglial Activation and β-Amyloid Deposit Reduction Caused by a Nitric Oxide-Releasing Nonsteroidal Anti-Inflammatory Drug in Amyloid Precursor Protein Plus Presenilin-1 Transgenic Mice
2002
Noncytopathic Sindbis virus RNA vectors for heterologous gene expression
1998 StandoutNobel
The Long Third Complementarity-Determining Region of the Heavy Chain Is Important in the Activity of the Broadly Neutralizing Anti-Human Immunodeficiency Virus Type 1 Antibody 2F5
2004
Generation of cytotoxic and humoral immune responses by nonreplicative recombinant Semliki Forest virus.
1995
Elicitation of structure-specific antibodies by epitope scaffolds
2010 StandoutNobel
Prospects for the Future
2002 StandoutScienceNobel
A sindbis virus mRNA polynucleotide vector achieves prolonged and high level heterologous gene expressionin vivo
1995
Mouse neurexin-1α deletion causes correlated electrophysiological and behavioral changes consistent with cognitive impairments
2009 StandoutNobel

Works of Kenneth E. Ugen being referenced

Phase I Trial of Interleukin-12 Plasmid Electroporation in Patients With Metastatic Melanoma
2008
Number of A β Inoculations in APP+PS1 Transgenic Mice Influences Antibody Titers, Microglial Activation, and Congophilic Plaque Levels
2001
Construction of a Recombinant Bacterial Human CD4 Expression System Producing a Bioactive CD4 Molecule
1992
T-cell responses induced in normal volunteers immunized with a DNA-based vaccine containing HIV-1 env and rev
2002
DNA Inoculation Induces Neutralizing Immune Responses Against Human Immunodeficiency Virus Type 1 in Mice and Nonhuman Primates
1993
First Human Trial of a DNA-Based Vaccine for Treatment of Human Immunodeficiency Virus Type 1 Infection: Safety and Host Response
1998
Therapeutic immunization of HIV-infected chimpanzees using HIV-1 plasmid antigens and interleukin-12 expressing plasmids
2000
A Human Monoclonal Antibody to HIV-1 gp41 with Neutralizing Activity Against Diverse Laboratory Isolates
1996
Microglial activation facilitates Aβ plaque removal following intracranial anti-Aβ antibody administration
2003
Vertical transmission of human immunodeficiency virus (HIV) infection. Reactivity of maternal sera with glycoprotein 120 and 41 peptides from HIV type 1.
1992
Cloning and biological characterization of human single-chain Fv fragments that mediate neutralization of HIV-1
1994
Optimized and enhanced DNA plasmid vector based in vivo construction of a neutralizing anti-HIV-1 envelope glycoprotein Fab
2013
Safety and immunogenicity of HIV-1 DNA constructs in chimpanzees
1998
The Galactosyl Ceramide/Sulfatide Receptor Binding Region of HIV-1 gp120 Maps to Amino Acids 206-275
1993
In vivo protective anti‐HIV immune responses in non‐human primates through DNA immunization
1996
Protection of chimpanzees from high-dose heterologous HIV-1 challenge by DNA vaccination
1997
Antigen‐specific humoral and cellular immune responses can be modulated in rhesus macaques through the use of IFN‐γ, IL‐12, or IL‐18 gene adjuvants
1999
Direct vs. Indirect Modulation of Complex IN VITRO Human Retroviral Infections by Morphine
2006
TGFβ1 regulation of collagen metabolism by embryonic palate mesenchymal cells
1994
An Anti-gp41 Human Monoclonal Antibody That Enhances HIV-1 Infection in the Absence of Complement
1994
Mucosal immunization with a DNA vaccine induces immune responses against HIV-1 at a mucosal site
1997
An HIV Type 2 DNA Vaccine Induces Cross-Reactive Immune Responses against HIV Type 2 and SIV
1997
Enhancement of protective humoral (Th2) and cell-mediated (Th1) immune responses against herpes simplex virus-2 through co-delivery of granulocyte-macrophage colony-stimulating factor expression cassettes
1998
Aβ peptide vaccination prevents memory loss in an animal model of Alzheimer's disease
2000 Nature
Synthesis and conformational studies of N-glycosylated analogs of the HIV-1 principal neutralizing determinant
1992
Functional role of platelets in experimental metastasis studied with cloned murine fibrosarcoma cell variants.
1988
Induction of multiple flagella in Naegleria: Requirements for RNA and protein synthesis
1979
Intracranially Administered Anti-Αβ Antibodies Reduce β-Amyloid Deposition by Mechanisms Both Independent of and Associated with Microglial Activation
2003
Identification of CD7 glycoprotein as an accessory molecule in HIV-1-mediated syncytium formation and cellfree infection.
1994
Intracranially administered anti-Abeta antibodies reduce beta-amyloid deposition by mechanisms both independent of and associated with microglial activation.
2003
Gene inoculation generates immune responses against human immunodeficiency virus type 1.
1993
Modulation of Antigen-Specific Humoral Responses in Rhesus Macaques by Using Cytokine cDNAs as DNA Vaccine Adjuvants
2000
Rankless by CCL
2026